Delivery Order SPE2DB20D1051-SPE2DB25FD7TT

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,822.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a performance period ending on May 6, 2025. This contract is not set-aside and was awarded on a firm fixed-price basis. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $1,722.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,753.19 delivery order contract is a firm fixed-price, non-set-aside award for the supply of the prescription medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
This federal contract award, valued at $24,979.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 17, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,914.97 firm-fixed-price delivery order is for the supply of the medication WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of May 23, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
The federal contract award is for $23,930.36 and was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, and has a firm fixed price pricing type with an ultimate completion date of March 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,501.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. This is a firm-fixed-price delivery order contract with a completion date of February 18, 2025. The contract is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.50 firm fixed-price delivery order is for the provision of the medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a performance period extending through May 19, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,314.16 Firm Fixed Price Delivery Order is for the supply of the prescription medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a performance period through May 7, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,443.86 firm fixed-price delivery order is for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of May 14, 2025 and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB25FD7TT
    Delivery Order

This federal contract award, valued at $18,503.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, with a performance period extending until April 18, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 2:27 PM